Claritev (CTEV) Long-Term Debt Issuances (2020 - 2021)
Claritev's quarterly Long-Term Debt Issuances came in at -$264.4 million in Q4 2021, down 126059.83% quarter-over-quarter from -$209600.0 in Q3 2020.
Claritev has reported Long-Term Debt Issuances for 2 years, with the latest figure at -$264.4 million in Q4 2021.
- For the quarter ending Q4 2021, Long-Term Debt Issuances changed N/A year-over-year to -$264.4 million; the trailing twelve-month figure through Dec 2022 stood at -$264.6 million (changed 0.0% YoY), and the FY2021 full-year result was $1.0 billion, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2021 stood at -$264.4 million, down from -$209600.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $209600.0 in Q1 2020, with the low at -$264.4 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 19.80 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Claritev | 456.62 Mn | 428.62 Mn | 175.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -264.43 Mn |
| Dec 31, 2021 | -264.43 Mn |
| Sep 30, 2020 | -209,600.00 |
| Sep 30, 2020 | -209,600.00 |
| Mar 31, 2020 | 209,600.00 |
| Mar 31, 2020 | 209,600.00 |